Loading...

Curaleaf Holdings, Inc.

CURA.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
CA$5.22
CA$0.44(9.21%)

Curaleaf Holdings, Inc. CURA.CN Peers

See (CURA.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$6.53+3.00%2.4B-38.41-CA$0.17N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$7.17+2.43%1.7B24.72CA$0.29N/A
CRON.TOCA$2.72+4.21%1B14.32CA$0.19N/A
TRUL.CNCA$5.40+0.37%1B-5.00-CA$1.08N/A
CURA.TOCA$1.22+3.39%877.7M-2.54-CA$0.48N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
DHT-UN.TOCA$12.96-0.23%729.8M324.00CA$0.04+3.90%
GUD.TOCA$6.00-0.33%597.8M60.00CA$0.10N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CURA.CN vs BHC.TO Comparison

CURA.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CURA.CN stands at 4.1B. In comparison, BHC.TO has a market cap of 2.4B. Regarding current trading prices, CURA.CN is priced at CA$5.22, while BHC.TO trades at CA$6.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CURA.CN currently has a P/E ratio of -6.07, whereas BHC.TO's P/E ratio is -38.41. In terms of profitability, CURA.CN's ROE is -0.25%, compared to BHC.TO's ROE of +0.03%. Regarding short-term risk, CURA.CN is more volatile compared to BHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CURA.CN.

Stock Price Comparison

Loading...

Frequently Asked Questions